Given its significance in regulating autophagy and apoptosis, targeting the BMI1/ATM/miR-16 circuit may hold therapeutic potential in treating NSCLC and cervical cancer by modulating cell survival and death responses. The gene discussed is BMI1; the disease is cervical cancer.